Drs. Group Urges FTC Antitrust Scrutiny Of Insulin Pricing
The American Medical Association wants the Federal Trade Commission to probe potential anti-competitive conduct by drugmakers that may be contributing to the soaring price of insulin, and it encouraged the agency...To view the full article, register now.
Already a subscriber? Click here to view full article